| Protein | Synonyms | Taxonomy |
|---|---|---|
| Replicase polyprotein 1ab | pp1ab; ORF1ab polyprotein | Severe acute respiratory syndrome coronavirus 2 |
| Interleukin-6 | IL-6; B-cell stimulatory factor 2; BSF-2; CTL differentiation factor; CDF; Hybridoma growth factor; Interferon beta-2; IFN-beta-2 | Homo sapiens (human) |
| Interleukin-18 | IL-18; Iboctadekin; Interferon gamma-inducing factor; IFN-gamma-inducing factor; Interleukin-1 gamma; IL-1 gamma | Homo sapiens (human) |
| ORF9c protein | ORF9c; Uncharacterized protein 14; ORF14 | Severe acute respiratory syndrome coronavirus 2 |
| Ribosomal protein S6 kinase, EC 2.7.11.1 | Homo sapiens (human) | |
| Tumor necrosis factor (TNF superfamily, member 2) (TNFA protein) | Homo sapiens (human) | |
| ORF9b protein | ORF9b; Accessory protein 9b; ORF-9b; Protein 9b | Severe acute respiratory syndrome coronavirus 2 |
| Compound | Description |
|---|---|
| angiotensin ii, des-phe(8)- | |
| angiotensin ii | An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. |
| angiotensin i | A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. |
| angiotensin i, ile(5)- |